Canadian Securities Exchange

Cannabinoid-focused biopharmaceutical company C3 Pharmaceuticals, Inc. announced Wednesday that it has executed a tailored share subscription agreement with GEM Global Yield LLC SCS and is planning on listing on the Canadian Securities Exchange. The California company said it has a commitment of...

Tryp Therapeutics Inc. (OTCQB:TRYPF), a Canadian biotech leader in psychedelics, has officially received approval from Exopharm Limited shareholders for their strategic merger, paving the way for a new entity, Tryptamine Therapeutics Limited. Key Merger Dates And Trading Halt This approval follows...

Lophos Holdings Inc., owner of a biosciences business licensed for the cultivation, research and sale of Peyote and other controlled substances, has received approval for the listing of its common shares on the Canadian Securities Exchange (CSE).  The company expects to start trading on...

  TerrAscend Corp. (OTCQX: TRSSF) (CSE: TER) announced that it has received conditional approval from the Toronto Stock Exchange to list its common shares on the TSX.   “I would like to express my sincere appreciation to the teams at the TSX, TerrAscend and Cassels for...

A cannabis company listed on the Canadian Securities Exchange, Chalice Brands Ltd. (CSE: CHAL), has recently obtained an order from the Ontario Superior Court of Justice for protection under the Companies Creditors Arrangement Act (CCAA) of Canada. In addition, the company has initiated a...

The Canadian Securities Exchange (CSE) announced a new senior tier that could benefit US cannabis companies by offering them a broader investor base and lower capital costs. The new tier will include 108 companies, 39 of which are marijuana businesses. By being on the senior tier, members will...

Vertically integrated cannabis operator, Stem Holdings, Inc. (OTCQB: STMH, CSE: STEM) announced that executed a term sheet for a proposed business combination with Headwaters, LLC, a California-based greenhouse cultivator. “Over the past 12 months, Stem has worked tirelessly to find the...

Medical cannabis and alternative medicines provider Optimind Pharma Corp. began trading on the Canadian Securities Exchange (CSE) under the ticker symbol "OMND". Despite the company’s primary business being medically-prescribed cannabis, due to its efficacy and safety profile,...

Raising capital in the current market is proving to be increasingly challenging for cannabis companies today. “The current cycle in which we’re in has brought valuations to a significantly low level,” says Luis Merchan, president and CEO of Flora Growth (NASDAQ: FLGC),...

Albert Labs, a British-Columbia based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.”  “The listing is the first...

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) disclosed Thursday its intentions to list its common shares and listed common share purchase warrants on the Canadian Securities Exchange. The move follows the finalization of the company's first international commercial shipment...

The MGO and ELLO Cannabis Practice recently launched its “The Cannabis 50” list. This industry highlight recognizes those who transformed, uplifted and inspired the growth and maturation of the cannabis industry with a focus on acts of impact this year. “In creating ‘The...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The uncertain regulatory environment in the U.S. has not stopped the cannabis industry from putting down roots in the secondary market....

iAnthus Capital CEO Hadley Ford, who will be presenting at the Cannabis Investor Day, speaking at the most recent Benzinga Cannabis Capital Conference. Roughly one year after the most momentous date in the industry’s history—Canada’s federal legalization—cannabis executives...

Investors may soon have the opportunity to invest in a new cannabis company. Avicanna, a Canadian cannabinoid-focused company, has filed a preliminary prospectus to go public in Canada. The company plans to apply for its listing on the Canadian Securities Exchange. About Avicanna Avicanna focuses...